1. No category

13 MARCH 2015, FRIDAY
POSTER NO
PRESENTER
TITLE
PP - 1002
Necla Tulek
PP - 1003
Tatsuya Ohyama
MK-0626, A SELECTIVE DPP-4 INHIBIOR, AMELIOLATES HEPATIC STEATOSIS IN OB/OB MICE
PP - 1004
Xianghua Zeng
CCL20: A POTENTIAL PREDICTOR OF SIGNIFICANT LIVER FIBROSIS IN CHRONIC HEPATITIS B
PP - 1007
Yu-Tian Chong
COMPARISON OF THE EFFICACY OF TENOFOVIR DISOPROXIL FUMARATE AND ENTECAVIR FOR INITIAL TREATMENT OF PATIENT WITH
CHRONIC HEPATITIS B THROUGH 72 WEEKS IN CHINA
PP - 1009
Yujia Zhu
PP - 1012
Xueping Yu
PP - 1013
Wei Jia
PP - 1014
Jee-Fu Huang
THE INTERACTION BETWEEN METABOLIC FACTORS AND DISEASE PROGRESSION IN NONALCOHOLIC STEATOHEPATITIS PATIENTS
PP - 1024
Myung Jin Oh
TENOFOVIR MAY SHOW COMPARABLE SAFETY AND ANTIVIRAL EFFICACY FOR TREATMENT-NAÏVE KOREAN HEPATITIS B PATIENTS
UNDER 50 YEARS AS WELL AS OVER 50 YEARS IN AGE
PP - 1036
Nassıma Belabas
EFFICACY AND SAFETY OF TENOFOVIR DISOPROXIL FUMARATE + LAMIVUDINE COMBINATION IN THE TREATMENT OF CHRONIC
HEPATITIS B: RESULTS OF A COHORT IN AN INFECTIOUS DISEASES UNIT.
PP - 1038
Nassıma Belabas
EPIDEMIOLOGICAL CHARACTERISTICS OF PEOPLE LIVING WITH HUMAN IMMUNODEFICIENCY VIRUS CO-INFECTED WITH HEPATITIS B
VIRUS IN AN INFECTIOUS DISEASES UNIT: AN OVERVIEW
SERUM HEPATITIS B SURFACE ANTIGEN QUANTIFICATION IN THE PATIENTS WITH CHRONIC HEPATITIS B INFECTION
COMPARISON OF TELBIVUDINE AND ENTECAVIR TREATMENT OF NUCLEOSIDE-ANALOGUES NAÏVE CHRONIC HEPATITIS B FOR 144
WEEKS.
TGF-β1/IL-23 PATHWAY IS UP-REGULATED IN PATIENTS WITH ACUTE-ON-CHRONIC HEPATITIS B LIVER FAILURE AND IS
ASSOCIATED WITH DISEASE SEVERITY AND SURVIVAL
ORIGINAL SCIENTIFIC PAPER: ANTIBODY TO HEPATITIS CORE ANTIGEN LEVELS IN THE NATURAL HISTORY OF CHRONIC HEPATITIS B
PP - 1041
Nassıma Belabas
PROFILE OF INFECTED CONSULTANTS BY HEPATITIS B VIRUS AND HEPATITIS C VIRUS : EXPERIENCE A FREE TESTING CENTER.
PP - 1042
Nassıma Belabas
THE ACCEPTABILITY OF SCREENING FOR HUMAN IMMUNODEFICIENCY VIRUS - HEPATITIS C AND B VIRUS INFECTIONS AMONG
PREGNANT WOMEN: RESULTS OF A SURVEY IN A TESTING CENTER IN ALGIERS.
PP - 1044
Chaoyu Xu
COMPARISON OF THE EFFICACY OF ENTECAVIR, LAMIVUDINE, ADEFOVIR DIPIVOXIL AND TELBIVUDINE IN TREATING NAS-NAIVE
PATIENTS IN CHINA.
PP - 1055
Wenjin Ding
EFFECTS OF GLUTAMINE ON INTERCELLULAR JUNCTION PROTEIN EXPRESSION OF INTESTINAL EPITHELIUM IN RATS WITH
NONALCOHOLIC FATTY LIVER DISEASE
PP - 1061
Fehmi Tabak
IMPACT OF TENOFOVIR DISOPROXIL FUMARATE ON THE FASTING LIPID PROFILE OF CHRONIC HEPATITIS B PATIENTS
PP - 1068
İbrahim Hatemi
PP - 1069
Kozıelewıcz Dorota
PP - 1070
Selcuk Kaya
PP - 1076
Sebahat Basyigit
PP - 1077
Y. Yang
PP - 1082
M Golam Azam
PP - 1085
Aq Taguba
WILSON’S DISEASE: A RETROSPECTIVE ANALYSIS
TENOFOVIR THERAPY IN CHRONIC HEPATITIS B PATIENTS WHO FAILED PREVIOUS NUCLEOSIDE ANALOGUES TREATMENT
HEPATITIS B AND C VIRUS (HBV AND HCV) PREVALANCE IN HIV/AIDS PATIENTS WHICH FOLLOW IN OUR CLINIC
RELATIONSHIP BETWEEN INSULIN RESISTANCE, NON-ALCOHOLIC FATTY LIVER DISEASE AND COLORECTAL CARCINOMA
COST-EFFECTIVENESS ANALYSIS OF ANTIVIRAL THERAPIES IN PATIENTS WITH HBEAG-POSITIVE CHRONIC HEPATITIS B IN CHINA
PREDICTORS OF RESPONSE TO 2 YEARS TELBIVUDINE THERAPY AMONG CHRONIC HEPATITIS B PATIENTS IN BANGLADESH: A ‘REALLIFE’ EXPERIENCE OF 471 CASES
PREVALENCE AND RISK FACTORS OF HEPATITIS B INFECTION IN PREGNANT WOMEN AT THE PRENATAL CLINIC OF THE UNIVERSITY OF
THE PHILIPPINES- PHILIPPINE GENERAL HOSPITAL
PP - 1087
Shahinul Alam
INSULIN RESISTANCE IN NONALCOHOLIC FATTY LIVER DISEASE: REVALIDATION OF OLD CONCEPT IN THE NEW ERA
PP - 1091
Sayfullo Avezov
CHRONIC PANCREATITIS LINKED TO OBESITY IN TAJIKISTAN
PP - 1096
Yufeng Gao
PP - 1101
Yuri Cho
PP - 1105
Myung Seok Lee
PP - 1108
Kuerbanjiang Abuduxikuer
PP - 1110
Jie Li
PP - 1117
Hasan Ali
PP - 1120
Giuseppe Cerasari
PP - 1122
Eunae Cho
PP - 1125
Burak Suvak
HEPATITIS B AND HEPATITIS C PREVALENCE IN PATIENTS WITH GASTRIC ADENOCARCINOMA
PP - 1128
Chun-Jen Liu
INTERFERON THERAPY REDUCED INCIDENCE OF HEPATOCELLULAR CARCINOMA AND MORTALITY IN CHRONIC HEPATITIS B PATIENTS
COMPARATIVE STUDY OF TELBIVUDINE AND PEGYLATED INTERFERON α-2A OPTIMIZATION THERAPY FOR E ANTIGEN-POSITIVE
CHRONIC HEPATITIS B PATIENTS
COMPARISON OF THE EFFICACIES OF ENTECAVIR 0.5 AND 1.0 MG COMBINED WITH ADEFOVIR IN PATIENTS WITH CHRONIC
HEPATITIS B WHO HAD FAILED ON PRIOR NUCLEOS(T)IDE ANALOGUE TREATMENTS
SHORT-TERM LOW-DOSE THIAZOLIDINEDIONES CAN BE A USEFUL BRIDGING THERAPY IN NASH PATIENTS WITHOUT SIDE EFFECTS
WILSON DISEASE WITH HEPATIC PRESENTATION IN AN 8-MONTH-OLD BOY
IL-21 PROMOTES HEPATITIS B VIRUS ANTIGEN-SPECIFIC CD8+ CYTOTOXIC T LYMPHOCYTES RESPONSE IN CHRONIC HEPATITIS B
PATIENTS
CORRELATION BETWEEN ANTHROPOMETRIC MEASURES, LIPID PROFILE AND SERUM ADIPONECTIN AND STEATOSIS IN NONDIABETIC
NONALCOHOLIC FATTY LIVER DISEASE
PREGNANCY IN A WOMAN WITH BUDD CHIARI SYNDROME
RISK FACTORS OF HBV REACTIVATION IN PATIENTS UNDERWENT HEMATOPOIETIC STEM CELL TRANSPLANTATION IN HBV ENDEMIC
AREA
PP - 1131
Gautam Ray
A STUDY OF METABOLIC PARAMETERS IN NON DIABETIC PATIENTS OF FATTY LIVER WHO DO NOT CONSUME ALCOHOL
PP - 1138
Sheikh Mohammad Fazle
Akbar
PP - 1142
Ruksana Raihan
IMMUNOFLUORESCENCE DETECTION OF HEPATITIS B CORE ANTIGEN IN FORMALIN FIXED OR FROZEN SECTIONS OF LIVER BIOPSIES
FROM CHRONIC HEPATITIS B PATIENTS IN BANGLADESH
PP - 1143
Ruksana Raihan
DETECTION OF HEPATITIS B CORE ANTIGEN IN HEPATOCYTES OF CHRONIC HEPATITIS B PATIENTS: COMPARISON BETWEEN INDIRECT
IMMUNOFLUORESCENCE AND IMMUNOPEROXIDASE METHODS
PP - 1150
Sungkyu Choi
PP - 1160
Sheng-Hao Yun
PP - 1161
Ramazan Idilman
PP - 1162
Jem Ma Ahn
PP - 1164
Hong Soo Kim
PP - 1171
Yuan Xue
QUASISPECIES CHARACTERISTICS OF CPG ISLANDS AND INHIBITORY GUANOSINE-RICH OLIGODEOXYNUCLEOTIDES DIFFER ACROSS
SPECTRUM OF HEPATITIS B VIRUS INFECTION
PP - 1172
Abhasnee Sobhonslidsuk
THE EVALUATION OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND ITS ASSOCIATE FACTORS IN PSORIASIS PATIENTS USING
ULTRASONOGRAPHY AND THE CONTROLLED ATTENUATION PARAMETER (CAP) MEASURED WITH TRANSIENT ELASTOGRAPHY
PP - 1173
Emel Ahıshalı
DICHOTOMY OF ANTIVIRAL EFFECT AT END OF TREATMENT AND DURING OFF-TREATMENT PERIOD IN PATIENTS WITH CHORNIC
HEPATITIS B TREATED BY THERAPEUTIC VACCINE VRESUS PEGYLATED INTERFERON
PYOGENIC LIVER ABSCESS IN THE ELDERLY: CLINICAL CHARACTERISTICS, OUTCOMES IN KOREAN PATIENTS OLDER THAN 65 YEARS
ASSOCIATION BETWEEN AGE AND SEROCONVERSION IN INITIAL HBV PATIENTS
THE ROLE OF GENETIC VARIABILITY OF PNPLA3 (RS738409) ON HISTOLOGICAL PROGRESSION OF NON-ALCOHOLIC FATTY LIVER
DISEASE
RELATIONSHIP BETWEEN HEPATIC STEATOSIS ASSESSED BY ULTRASOUND AND CONTROLLED ATTENUATION PARAMETER IN
PATIENTS WITH ALCOHOLIC LIVER DISEASE AND THOSE WITH NON-ALCOHOLIC FATTY LIVER DISEASE
EFFICACY OF TENOFOVIR RESCUE THERAPY FOR DRUG-RESISTANT CHRONIC HEPATITIS B PATIENTS : ONE YEAR MULTICENTER
EXPERIENCE IN KOREA
DOES INSULIN RESISTANCE AFFECT THE RESPONSE OF CHRONIC B HEPATITIS TO PEGYLATED INTERFERON TREATMENT?
KINETICS OF HEPATITIS B SURFACE ANTIGEN DECLINE DURING 3 YEARS OF TELBIVUDINE TREATMENT IN HEPATITIS B E
ANTIGENNEGATIVE PATIENTS IN CHANGZHOU, CHINA
PP - 1175
Xiao-Gang Zhang
PP - 1180
Youde Liu
PP - 1182
Behnaz Riazalhosseini
PP - 1183
Yang Ding
DURABILITY OF HBEAG SEROCONVERSION OF TELBIVUDINE AS MONOTHERAPY AND AS COMBINATION THERAPY WITH ADEFOVIR
DIPIVOXIL FOR CHRONIC HEPATITIS B PATIENTS WITH HIGH ALT LEVEL: A PROSPECTIVE, MULTICENTER, COHORT STUDY
PP - 1184
Byung Seok Kim
LONG-TERM EFFICACY OF ENTECAVIR MONOTHERAPY FOR PARTIAL VIROLOGIC RESPONSE TO ENTECAVIR IN TREATMENT-NAÏVE
CHRONIC HEPATITIS B PATIENTS
PP - 1187
Hong Soo Kim
PREDICTIVE FACTORS OF SUSTAINED REMISSION AFTER DISCONTINUING ANTIVIRAL THERAPY IN PATIENTS WITH HBEAG-POSITIVE
CHRONIC HEPATITIS B: MULTI-CENTER EXPERIENCE
PP - 1189
Xiaoling Chi
THE PREDICTION VALUE OF SERUM HBSAG AND HBEAG IN HBEAG SEROCONVERSION AFTER NUCLEOSIDE ANALOGUE THERAPY
PP - 1194
Pathik Parikh
AN OPEN LABEL RANDOMIZED CONTROL STUDY TO COMPARE THE EFFICACY OF VITAMIN E VERSUS URSODEOXYCHOLIC ACID IN
NON DIABETIC INDIAN NAFLD PATIENTS
PP - 1195
Pathik Parikh
PREVALENCE OF HYPOTHYROIDISM IN NONALCOHOLIC FATTY LIVER DISEASE PATIENTS IN WESTERN INDIA
PP - 1196
Quan Zhang
LOSS OF FGF21 IN DIABETIC MOUSE DURING HEPATOCELLULAR CARCINOGENETIC TRANSFORMATION
PP - 1197
Pathik Parikh
SERUM FERRITIN LEVELS IN PREDICTING HISTOLOGICAL SEVERITY IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE IN INDIA.
PP - 1199
Yi Yang
COMPARISON OF HBEAG SEROCONVERSION RATE AMONG HBEAG-POSITIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH LDT
AND ETV USING PROPENSITY SCORE MATCHING METHODS
MICRORNA PROFILING TO IDENTIFY CHRONIC HEPATITIS B INDIVIDUALS AT RISK OF LIVER DISEASE PROGRESSION
ANTIVIRAL DRUG UTILIZATION AND COSTS FOR INPATIENTS WITH CHRONIC HEPATITIS B IN GUANGZHOU, CHINA
PP - 1200
Makoto Arai
DIFFERENT DYNAMICS OF HBV RELATED ANTIGEN DURING ENTECAVIR TREATMENT
PP - 1201
Dilara Inan
PP - 1203
Kathryn Kitrinos
NO DETECTABLE RESISTANCE TO TENOFOVIR DISOPROXIL FUMARATE IN HBEAG+ AND HBEAG- PATIENTS WITH CHRONIC HEPATITIS B
AFTER EIGHT YEARS OF TREATMENT
PP - 1205
Yukitomo Urata
STUDY OF HEPATITIS B MARKERS IN PATIENTS WITH RHEUMATOID ARTHRITIS
PP - 1206
Takashi Taida
PP - 1207
Yue Qi
PP - 1208
Ching-Chung Lin
PP - 1221
Xiaoling Chi
PP - 1222
Arttrika Ranjan
PP - 1226
Özlem Altundaş Aydın
HAEMOCHROMATOSIS IN LIVER: A CASE REPORT
PP - 1228
Özlem Altuntaş Aydın
CORRELATION OF SERUM HBS ANTIGEN AND AMINOTRANSFERASE LEVELS WITH LIVER HISTOPATHOLOGY IN VIRAL HEPATITIS
PP - 1237
So Young Kwon
TUBERCULOSIS LYMPHADENITIS DURING PEGYLATED INTERFERON-ALFA AND RIBAVIRIN THERAPY FOR PATIENT COINFECTED WITH
HEPATITIS B VIRUS AND HEPATITIS C VIRUS
ESTIMATION OF ALT FLUCTUATION IN THE PAST 10 YEARS BY NON-INVASIVE TEST
RELATIONSHIP BETWEEN E ANTIGEN SEROCONVERSION AND IMPROVED LIVER HISTOLOGY IN PATIENTS TREATED BY TELBIVUDINE
FOR CHRONIC HEPATITIS B
THE DURABILITY OF EFFICACY AND PREDICTOR AFTER THREE YEARS NUCLEOS(T)IDE ANALOG OFF-TREATMENT IN CHRONIC
HEPATITIS B PATIENTS
THE ROLE OF SERUM HBSAG AND TRADITIONAL CHINESE MEDICINE SYNDROMES IN PREDICTING SIGNIFICANT FIBROSIS IN CHRONIC
HEPATITIS B PATIENTS
EXPRESSION PATTERN OF CHEMOKINES IP-10 AND RANTES IN PATIENTS SUFFERING FROM HEPATITIS B.
VIROLOGIC RESPONSE AND SAFETY OF TENOFOVIR VS. ENTECAVIR IN TREATMENT-NAÏVE CHRONIC HEPATITIS B PATIENTS.
PP - 1238
Xiaomei Wang
EFFICACY AND SAFETY OF TELBIVUDINE AND ENTECAVIR FOR HBEAG-POSITIVE CHRONIC HEPATITIS B
PP - 1241
Yufeng Xing
PP - 1244
Nese Demirturk
PP - 1246
Muharrem Coşkun
PP - 1249
İbrahim Hatemi
COMPARISON OF HISTOPATHOLOGICAL FIBROSIS STAGE WITH FIBROSCAN FINDINGS IN CHRONIC HEPATITIS B
PP - 1255
Mingxing Huang
EFFICACY OF ENTECAVIR AND TELBIVUDINE IN HBEAG POSITIVE CHRONIC HEPATITIS B PATIENTS
PP - 1257
Sang Bong Ahn
CARBOHYDRATE AND SIMPLE SUGAR CONSUMPTION IS RELATED WITH NON-ALCOHOLIC FATTY LIVER DISEASE
PP - 1258
Young Kul Jung
SEVERAL FACTORS COULD BE CONSIDERED WHEN APPLYING THE LIVER STIFFNESS BY TRANSIENT ELASTOGRAPHY IN HBV INFECTED
PATIENTS
PP - 1259
Hakan Dursun
RETROSPECTIVE EVALUATION OF HBEAG/ANTI-HBE ANTIBODY STATUS, LIVER HISTOLOGY AND ALT CONCENTRATIONS IN ADULT
TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS B DISEASE
PP - 1262
Jeong Han Kim
ADEFOVIR-ENTECAVIR COMBINATION RESCUE THERAPY FOR PREVIOUS CHRONIC HEPATITIS B TREATMENT FAILURE; 3 YEARS DATA
PP - 1265
Neeraj Saraf
PP - 1266
Cheng-Yuan Peng
EFFICACY OF A CHINESE HERBAL FORMULA ON BLOOD LIPID INDICATORS IN NON-ALCOHOLIC STEATOHEPATITIS RATS
EFFECT OF IL-28 B POLYMORPHISMS ON THE NATURAL COURSE OF HBV INFECTION
INACTIVE HBSAG CARRIER STATE: A SINGLE CENTER EXPERIENCE
ESTIMATION OF NORMAL VALUES OF SERUM TRANSAMINASES BASED ON LIVER HISTOLOGY IN HEALTHY ASIAN INDIANS
KINETICS OF QUANTITATIVE SERUM HBSAG DECLINE DURING SEVEN YEARS OF NUCLEOS(T)IDE ANALOGUE THERAPY IN CHRONIC
HEPATITIS B PATIENTS
PP - 1267
İbrahim Hatemi
WILSON’S DISEASE: A RETROSPECTIVE ANALYSIS
PP - 1270
Umaporn Limothai
SINGLE NUCLEOTIDE POLYMORPHISM OF HLA-DPA1 IS ASSOCIATED WITH TREATMENT RESPONSE TO PEGYLATED INTERFERON IN
THAI PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B
PP - 1279
Umaporn Limothai
THE ASSOCIATION OF INTERFERON-GAMMA INDUCED PROTEIN-10 (IP-10) POLYMORPHISM AND TREATMENT RESPONSE TO
PEGYLATED INTERFERON IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B
PP - 1282
Danny Wong
PP - 1285
Peng Hu
HEPATITIS B VIRUS REVERSE TRANSCRIPTASE MUTATIONS IN THE NATURAL HISTORY OF CHRONIC HEPATITIS B
PP - 1286
Xianghua Zeng
INFLUENCE OF HEPATIC INFLAMMATION ON FIBROSCAN IN DIAGNOSING FIBROSIS WITH CHRONIC HEPATITIS B
PP - 1287
Kazuya Okushin
EXPRESSION OF ABC TRANSPORTER, BILE SALT EXPORT PUMP, IS INVERSELY CORRELATED WITH NAFLD ACTIVITY SCORE IN THE LIVER
OF PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
PP - 1288
Xianghua Zeng
EFFECTIVENESS OF SEVERAL SIMPLE AND NONINVASIVE MODELS IN ASSESSING LIVER FIBROSIS IN PATIENTS WITH CHRONIC
HEPATITIS B
PP - 1290
Sang Goon Shim
PP - 1295
Jidong Jia
PP - 1297
Yuki Hamada
PP - 1298
Hideyuki Tamai
REDUCTION OF HEPATITIS B CORE-RELATED ANTIGEN BY LONG TERM NUCLEOSIDE/NUCLEOTIDE ANALOGUE THERAPY AND ITS
CORRELATION WITH INTRAHEPATIC HBV DNA REDUCTION
COMPARISON OF THE EFFICACY OF TENOFOVIR AND ENTECAVIR FOR THE TREATMENT OF NUCLEOS(T)IDE-NAIVE PATIENTS WITH
CHRONIC HEPATITIS B
ASSESSMENT OF INITIAL NUCLEOS(T)IDE ANALOGUES FOR CHRONIC HEPATITIS B TREATMENT AMONG SECOND TIER CITY HOSPITALS
IN CHINA: A BASELINE REPORT OF THE EVOLVE STUDY
LAENNEC® DERIVED FROM HUMAN-PLACENTA IMPROVES TYPE 2 DIABETES COMPLICATING WITH NASH THROUGH NORMALIZING
IRON METABOLISM BY THE ACTION OF HEPCIDIN
ADD-ON PEGYLATED INTERFERON ALPHA-2A THERAPY IN ENTECAVIR-TREATED PATIENTS WITH CHRONIC HEPATITIS B
LAENNEC® (HEPCIDIN-CONTAINING BIOLOGICAL DRUG DERIVED FROM HUMAN-PLACENTA) CAN REPLACE THE PHLEBOTOMY ON
CONGENITAL IRON AND COPPER METABOLISM DISORDER
PP - 1300
Yuki Hamada
PP - 1313
Jınglan Jın
PP - 1316
Tadashi Inuzuka
THE VIRAL CHARACTERISTICS OF HBV REACTIVATION FROM OCCULT CARRIER STATUS TRIGGERED BY CHEMOTHERAPY OR
IMMUNOSUPPRESSIVE THERAPY
PP - 1324
Olfat Hammam
EFFECT OF ROSUVASTATIN OR/AND β-CAROTENE AND DIETARY CONTROL ON NON-ALCOHOLIC FATTY LIVER (NAFLD) IN RATS.
PP - 1327
Aliye Soylu
EFFICACY OF TELBIVUDINE AND LAMIVUDINE IN PATIENTS WITH CHRONIC HEPATITIS B
PP - 1328
Aliye Soylu
EFFICACY OF LAMIVUDINE IN PATIENTS WITH CHRONIC HEPATITIS OR CIRRHOSIS DUE TO HBV INFECTION
PP - 1329
Guangdong Tong
PP - 1332
Hang Zhang
PP - 1333
Cheng-Kun Liu
THERAPEUTIC EFFECTS OF TELBIVUDINE AND ENTECAVIR IN HEPATITIS B VIRUS-RELATED LIVER CIRRHOSIS
PP - 1336
Hsien-Chung Yu
TELBIVUDINE VERSUS LAMIVUDINE FOR ANTIVIRAL PROPHYLAXIS IN CHRONIC HEPATITIS B PATIENTS UNDERGOING CYTOTOXIC
CHEMOTHERAPY
PP - 1337
Ming-Shun Wu
AN OBSERVATIONAL STUDY TO COMPARE THE ESTIMATED GLOMERULAR FILTRATION RATE OF TELBIVUDINE IN CHRONIC HEPATITIS
B PATIENTS WITH OR WITHOUT CIRRHOSIS: 2-YEAR FOLLOW-UP DATA
PP - 1340
Kazunori Kawaguchi
THE CORRELATION BETWEEN ALT LEVEL AND GENE EXPRESSION OF HBV INFECTION
LONG-TERM FOLLOW-UP OUTCOME OF NON- ANTIVIRAL THERAPY IN PATIENTS WITH CHRONIC HEPATITIS B
HEPATITIS B VIRUS X PROTEIN SENSITIZES TRAIL-INDUCED HEPATOCYTE APOPTOSIS BY INHIBITING E3 UBIQUITIN LIGASE A20
HBV RELATED LIVER CANCER ENHANCES NOTCH LIGAND GENOMIC ABNORMALITY AND REPRESENTS POOR PROGNOSIS
PP - 1344
Şahin Çoban
THE UTILITY OF VWF-AG AS A MARKER AND VITRO SCORE IN PREDICTING OF LIVER FIBROSIS STAGE IN PATIENTS WITH CHRONIC
HEPATITIS B
PP - 1347
Seema Alam
PROFILE AND OUTCOME OF METABOLIC LIVER DISEASE IN UNDER FIVES WITH LIVER RELATED PEDIATRIC EMERGENCIES IN A
TERTIARY CARE PEDIATRIC HEPATOLOGY CENTRE.
PP - 1348
Mustafa K. Celen
PP - 1350
Chia-Lin Chang
OCCULT HBV INFECTION AND ITS ASSOCIATION WITH HEPATOCELLULAR CARCINOMA IN THE COMMUNITY-BASED LONG-TERM
FOLLOW-UP REVEAL COHORT
PP - 1354
Veronica Marin
INTERACTION BETWEEN HEPATOCYTES AND HEPATIC STELLATE CELLS AS A CRUCIAL FACTOR DURING FIBROGENESIS IN A NASH IN
VITRO MODEL
PP - 1355
Y Li
PP - 1356
Junji Furuse
MULTICENTER OBSERVATIONAL STUDY OF REACTIVATION OF HEPATITIS B VIRUS CAUSED BY CHEMOTHERAPY FOR SOLID TUMORS
PP - 1358
Junji Furuse
MULTICENTER OBSERVATIONAL STUDY OF REACTIVATION OF HEPATITIS B VIRUS CAUSED BY CHEMOTHERAPY WITH SORAFENIB
PP - 1367
Nopporn Charoenthong
PP - 1375
Young Mi Hong
PP - 1379
Ferruccio Bonino
PP - 1380
I-Cheng Lee
TELBIVUDINE VERSUS TENOFOVIR TREATMENT IN HBEAG-NEGATIVE CHRONIC HEPATITIS B PATIENTS: TREATMENT INTENSIFICATION
BASED ON ROADMAP CONCEPT
THE DIAGNOSTIC ACCURACY OF TRANSIENT ELASTOGRAPHY IN LIVER FIBROSIS STAGING IN PATIENTS WITH CHRONIC HEPATITIS B: A
META-ANALYSIS
TWO-YEAR EFFICACY OF THE REAL-WORLD “ROADMAP CONCEPT” FOR LAMIVUDINE THERAPY IN CHRONIC HEPATITIS B PATIENTS AT
SONGKLANAGARIND HOSPITAL
CONTROLLED ATTENUATION PARAMETER(CAP) ASSESSMENT MAY BE CLINICALLY USEFUL FOR LIVER TRANSPLANT PURPOSES
TOTAL HEPATITIS B CORE ANTIGEN ANTIBODY, A QUANTITATIVE NON-INVASIVE MARKER OF HEPATITIS B VIRUS INDUCED LIVER
DISEASE
THE PERFORAMCE OF CXCL9 AND IP-10 IN PREDICTING VIROLOGICAL RESPONSE IN PATIENTS WITH CHRONIC HEPATITIS B
UNDERGOING PEGINTERFERON ALFA-2A THERAPY
PP - 1382
Dengming He
ASSOCIATION BETWEEN POLYMORPHISMS OF SODIUM TAUROCHOLATE COTRANSPORTING POLYPEPTIDE GENE (SLC10A1) AND
DIFFERENT PHONOTYPE OF CHRONIC HBV INFECTION
PP - 1387
Ayca Eroglu
HEPATIC EXPRESSION OF ENDOCANNABINOID RECEPTORS IN NONALCOHOLIC STEATOHEPATITIS AND METABOLIC SYNDROME
PP - 1390
Can Dolapcioglu
PP - 1395
Ayse Batirel
PP - 1397
Huseyin Alkim
RAPID AND DRAMATIC RECOVERY OF A VERY LONG BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS ATTACK WITH SHORT-TERM
STEROID TREATMENT
PP - 1401
Murat Aladag
INFLUENCE OF TENOFOVIR ON THE RENAL FUNCTIONS IN THE TREATMENT OF HBV INFECTION
PP - 1403
Emel Ahıshalı
THE RATE OF ABCB4 AND ABCB11 MUTATIONS IN INTRAHEPATIC CHOLESTASIS OF PREGNANCY
PP - 1406
Natarajan Ravendhran
PP - 1409
Natthaya Chuaypen
PP - 1411
Danbi Lee
GENOMIC CHANGES IN GENOTYPE C HEPATITIS B VIRUS ASSOCIATED WITH THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA: A
COHORT OBSERVATIONAL STUDY
PP - 1422
Ruhua Li
CONCOMITANT NONALCOHOLIC FATTY LIVER DISEASE MAY NOT INFLUENCE FIBROSIS SEVERITY IN PATIENTS WITH CHRONIC
HEPATITIS B
PP - 1434
Salih Boga
EFFICACY OF “ENTECAVIR” IN THE TREATMENT-NAÏVE CHRONIC HEPATITIS B PATIENTS
PREVALENCE AND IMPACT OF COEXISTENCE OF HBSAG AND ANTI-HBS POSITIVITY IN PATIENTS WITH CHRONIC HEPATITIS B
INFECTION
EPIDEMIOLOGIC SURVEY OF CHRONIC HEPATITIS B AND C IN THE BURMESE POPULATION OF MARYLAND
ALTERATION OF INTRAHEPATIC CCCDNA LEVELS IN PATIENTS WITH HBEAG-POSITIVE CHRONIC HEPATITIS B TREATED WITH
PEGYLATED INTERFERON
COLITIS DURING TRIENTINE THERAPY FOR WILSON DISEASE : A CASE REPORT
PP - 1435
Hulya Aladag
SAFETY AND RELIABILITY OF TENOFOVIR THERAPY IN PREGNANCY AND LACTATION PERIOD
PP - 1437
Jessica Liu
ASSOCIATION BETWEEN ALCOHOL DRINKING AND HEPATITIS B RELATED HEPATOCELLULAR CARCINOMA IS NOT MODIFIED BY
GENETIC POLYMORPHISMS OF ADH1B AND ALDH2
PP - 1438
Yanwei Zhong
APPLICATION OF GENE CHIP TECHNIQUE IN THE DETECTION OF HBV SURFACE ANTIGEN "A" DETERMINANT GENE MUTATIONS
PP - 1442
Murat Aladag
THE EFFECT OF TENOFOVIR ON SERUM PHOSPHOR CONCENTRATIONS IN CHRONIC HBV
PP - 1443
Ahmet Cumhur Dülger
PP - 1444
Meifang Han
PP - 1451
Atsushi Suetsugu
PP - 1464
Ym Wang
THE EFFICACY AND SAFETY OF TELBIVUDINE OR TENOFOVIR DISOPROXIL IN PRENGANCEY FOR PREVENTION OF MOTHER-TO-CHILD
TRANSMISSION OF HEPATITIS B VIRUS
PP - 1466
Mohammad Golam Azam
SEQUENTIAL THERAPY OF CHRONIC HEPATITIS B WITH PEGINTERFERON ALPHA 2A FOR 24 WEEKS FOLLOWED BY TENOFOVIR IN A
DEVELOPING COUNTRY
PP - 1474
Ju-Yeon Cho
PP - 1477
Juanjuan Zhao
PP - 1481
Mehmet Bayram
HEPATITIS B PREVALENCE AMONG SYRIAN IMMIGRANTS IN TURKEY.
HIGHLY EXPRESSION OF TUMOR NECROSIS FACTOR-RELATED APOPTOSIS-INDUCING LIGAND (TRAIL) AND ITS RECEPTORS DR4 AND
DR5 CORRELATING WITH THE SEVERITY OF DISEASE IN CHRONIC HBV INFECTION
HEPATITIS B VIRUS REACTIVATION IN LYMPHOMA PATIENTS WITH RITUXIMAB THERAPY
BASELINE QUANTITATIVE HBSAG LEVEL IS PREDICTIVE OF VIROLOGIC RESPONSE IN ENTECAVIR TREATED PATIENTS
IMPAIRED ANTI-FIBROTIC ACTIVITY OF NATURAL KILLER CELLS IS DEPENDENT ON HEPATIC STELLATE CELLS-DERIVED TGF-β AND
ENGULF IN LIVER CIRRHOSIS WITH CHRONIC HBV INFECTION
TELBIVUDINE THERAPY IN PATIENTS WITH CHRONIC HEPATITIS B INFECTION: REAL LIFE EXPERIENCE FROM TURKEY
PROFILE AND OUTCOME OF METABOLIC LIVER DISEASE IN UNDER FIVES WITH LIVER RELATED PEDIATRIC EMERGENCIES IN A
TERTIARY CARE PEDIATRIC HEPATOLOGY CENTRE.
PP - 1488
Seema Alam
PP - 1493
Naranjargal Dashdorj
PP - 1498
Sabiye Akbulut
PP - 1503
Yiqiong Jia
IMPAIRED FUNCTION OF CD4+ T FOLLICULAR HELPER (TFH) CELLS ASSOCIATED WITH HEPATOCELLULAR CARCINOMA PROGRESSION
PP - 1505
Celal Ayaz
TENOFOVIR ON-TREATMENT HBSAG LOSS IN NAIVE HBEAG NEGATIVE CHRONIC HEPATITIS B: A CASE REPORT
PP - 1509
Mingxing Huang
INFLUENCE OF ENTECAVIR ON HEPATIC FUNCTION OF CHRONIC HEPATITIS B FOR THE FIRST 12 WEEKS
PP - 1510
Tetsuya Hosaka
IMPACT OF NUCLEOS(T)IDE ANALOGUES TREATMENT AND INTRAHEPATIC VIRAL LOADS ON THE POST-OPERATIVE RECURRENCE
AMONG PATIENTS WITH HEPATITS B VIRUS RELATED HEPATOCELLULAR CARCINOMA
PP - 1512
Ali Kaya
PP - 1518
Yuk Fai Lam
PP - 1524
Nasrin Taghizadieh
PP - 1526
Dengming He
LIVER HISTOLOGY IN IMMUNE TOLERANCE PHASE PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION ACCORDING TO
DIFFERENT ALANINE TRANSAMINASE LEVEL
PP - 1528
Murat Aladağ
LONG TERM EFFECTIVENESS OF ENTECAVIR THERAPY IN CASES WITH CHRONIC HBV
MOTHER-TO-CHILD TRANSMISSION OF HBV AND HCV IN MONGOLIA
HEALTHY CHILD BIRTH IN SPITE OF ENTECAVIR TREATMENT
EVALUATION OF DIFFERENT ORAL ANTIVIRAL THERAPIES FOR CHRONIC HEPATITIS B INFECTION IN NON-CIRRHOTIC PATIENTS
CONTINUOUS ENTECAVIR FOR TREATMENT-NAÏVE CHINESE CHRONIC HEPATITIS B PATIENTS IN THE REAL WORLD SETTING: THE
SEVEN- YEAR RESULTS
RELATION BETWEEN SMOKIING AND NON ALCHOLIC FATTY LIVER DISEASE
PP - 1529
Myung Jin Oh
ANTIVIRAL EFFICACY OF ENTECAVIR VERSUS ENTECAVIR PLUS ADEFOVIR FOR HEPATITIS B VIRUS RTA181V/T MUTANTS ALONE
PP - 1532
Dengming He
LIVER HISTOLOGY IN IMMUNE TOLERANCE PHASE PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION ACCORDING TO
DIFFERENT ALANINE TRANSAMINASE LEVEL
PP - 1534
Dengming He
LIVER HISTOLOGY IN IMMUNE TOLERANCE PHASE PATIENTS WITH CHRONIC HEPATITIS B VIRUS INFECTION ACCORDING TO
DIFFERENT ALANINE TRANSAMINASE LEVEL
PP - 1535
Junqiu Wu
PP - 1542
Şükran Köse
PP - 1547
Özlem Kandemir
PP - 1551
Hamid Wani
HIGH DOSE OF LAMIVUDINE AND RESISTANCE IN PATIENTS WITH CHRONIC HEPATITIS B
PP - 1558
Irem Akdemir
EFFECTIVITY OF ORAL ANTIVIRALS USED IN CHRONIC HEPATITIS B AND EFFECTS ON KIDNEY FUNCTION
PP - 1559
Abdurrahım Sayılır
PP - 1560
Murat Aladag
LONG-TERM OUTCOMES OF TENOFOVIR THERAPY IN THE CASES WITH CHRONIC HBV
PP - 1562
Ozcan Deveci
EXAMINING THE RELATIONSHIP BETWEEN FIBROSIS SCORE AND QUANTIFICATION OF HBSAG TITERS AND HBV DNA LEVEL IN
CHRONIC HEPATITIS B PATIENTS
PP - 1569
Alpaslan Tanoglu
ASSOCIATION BETWEEN IL12A, IL1B AND IL17A GENE POLYMORPHISMS AND HBEAG SEROCONVERSION IN CHRONIC HEPATITIS B
PATIENTS WHO RECEIVED ENTECAVIR TREATMENT
EVALUATION OF THE EFFICACY OF LAMIVUDINE VERSUS TELBIVUDINE IN THE TREATMENT OF NAIVE HEPATITIS B E ANTIGEN
(HBEAG) - NEGATIVE CHRONIC HEPATITIS B PATIENTS
KINETICS OF HEPATITIS B SURFACE ANTIGEN WITH NUCLEO(S)TIDE ANALOGUES
REACTIVATION OF OCCULT HEPATITIS B INFECTION WITHOUT MARKED IMMUNOSUPRESSION AND SPONTANEOUS
SEROCONVERSION
THE RELATIONSHIP BETWEEN SERUM FETUIN-A AND LIVER FIBROSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
(NAFLD)
NON-INVASIVE MEASUREMENT OF LIVER STEATOSIS AND FIBROSIS BY CONTROLLED ATTENUATION PARAMETER (CAP) AND
FIBROSCAN® IS USEFUL TO ACCESS CLINICOPATHOLOLOGIC CONDITIONS OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD).
PP - 1572
Kenichiro Enooku
PP - 1581
Zerrın Ascı
PP - 1585
Josephine Anne Lucero
PP - 1586
Deniz Ozkaya
PP - 1591
Wah Kheong Chan
A NOVEL 2-STEP APPROACH COMBINING THE NAFLD FIBROSIS SCORE AND LIVER STIFFNESS MEASUREMENT FOR PREDICTING
ADVANCED FIBROSIS
PP - 1592
Wah Kheong Chan
LIMITED UTILITY OF PLASMA M30 IN DISCRIMINATING NON-ALCOHOLIC STEATOHEPATITIS FROM STEATOSIS – A COMPARISON WITH
ROUTINE BIOCHEMICAL MARKERS
PP - 1593
Jong Seok Ju
PP - 1596
Sang Bong Ahn
PREDICTORS OF FATIGUE IN CHRONIC HEPATITIS B PATIENTS
PP - 1598
Ming-Yao Chen
EFFICACY OF VIRAL LOAD REDUCTION DURING CHEMOTHERAPY IN CHRONIC HEPATITIS B VIRUS INFECTION PATIENTS TAKING
NUCLEOSIDES FOR CHEMOPREVENTION
PP - 1599
Masaru Enomoto
LONG-TERM OUTCOME OF SEQUENTIAL THERAPY WITH LAMIVUDINE FOLLOWED BY INTERFERON IN NUCLEOSIDE-NAÏVE, HBEAGPOSITIVE PATIENTS WITH CHRONIC HEPATITIS B VIRUS GENOTYPE C INFECTION
PP - 1608
Kil Woo Lee
IMPACT OF HYPOTHYROIDISM ON DEVELOPMENT NON-ALCOHOLIC FATTY LIVER DISEASE; 4-YEAR RETROSPECTIVE COHORT STUDY
PP - 1613
Afshan Syed
AGE DEPENDANT COUNTER IMPACT OF FAT REDUCING AGENTS ON RENAL FUNCTION TEST OF DIET INDUCED NON ALCOHOLIC
FATTY LIVER DISEASE IN RATTUS NORVEGICUS.
SERUM CONCENTRATIONS OF ASYMMETRIC DIMETHYLARGININE IN CHRONIC HEPATITIS B PATIENTS
THE DOWNWARD SPIRAL OF ACUTE FATTY LIVER OF PREGNANCY: A CASE REPORT
SHOULD WE TAKE INTO ACCOUNT THE HISTORY OF HYPERTHYROIDISM DURING INTERFERON-ALPHA TREATMENT?
OUTCOME OF TENOFOVIR TREATMENT IN CHRONIC HEPATITIS B PATIENTS IN REAL-LIFE PRACTICE
PP - 1615
Şükran Köse
QUALITY OF LIFE IN PATIENTS WITH CHRONIC HEPATITIS B
PP - 1616
Salih Boga
PP - 1620
Abdullah Emre Yıldırım
PP - 1628
Hyun Yang
PP - 1632
Tsung-Hui Hu
A COMPARISON OF RENAL SAFETY OF TELBIVUDINE, ENTECAVIR, AND TENOFOVIR TREATMENT IN CHRONIC HEPATITIS B PATIENTS: A
SINGLE CENTER, LARGE “REAL-LIFE” COHORT STUDY
PP - 1636
Hsien-Chung Yu
CHANGES OF HEPATITIS B SURFACE ANTIGEN LEVELS IN CHRONIC HEPATITIS B PATIENTS WITH TELBIVUDINE TREATMENT FOR MORE
THAN 2 YEARS
PP - 1638
Yao-Li Chen
PP - 1647
Dong Jı
INCREASE RISK OF PROGRESSION TO LIVER CIRRHOSIS AND HEPATOCELLULAR CARCINOMA IN CHINESE CHRONIC HEPATITIS B
PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE
PP - 1648
Nesrin Turker
EVALUATION OF LAMIVUDINE FOR THE TREATMENT OF CHRONIC HEPATITIS B: PRE-REPORT OF REAL LIFE DATA FROM TURKEY
PP - 1651
Peng Hu
PP - 1659
Ergenekon Karagoz
PP - 1662
Levina S. Pakasi
MOLECULAR GENETIC DIAGNOSIS OF PFIC 3: OVERLAPPING PRESENTATION WITH WILSON DISEASE AND RESPONSE TO TREATMENT
THE RELATIONSHIP BETWEEN SIMPLE SERUM NATURAL ANTI-OXIDANT LEVELS IN NONALCOHOLIC FATTY LIVER DISEASE
LONG-TERM CLINICAL OUTCOME AFTER HEPATITIS B SURFACE ANTIGEN SEROCLEARANCE IN THE ENDEMIC AREA OF HEPATITIS B
VIRUS INFECTION
A FOLLOW UP STUDY ON THE EFFICACY OF TELBIVUDINE FOR HEPATITIS B VIRUS INFECTED TAIWANESE PATIENTS AFTER LIVING
DONOR LIVER TRANSPLANTATION
EFFICACY OF PEG-INTERFERON IN TREATMENT-EXPERIENCED PATIENTS WITH CHRONIC HEPATITIS B
A CASE OF PREDNISOLONE INDUCED ACUTE FLARE UP OF HBV INFECTION IN A PATIENT WITH OCULAR BEHCET DISEASE
NON-ALCOHOLIC FATTY LIVER AND NON-ALCOHOLIC FATTY PANCREAS DISEASES: PARTNER IN CRIME
PP - 1668
Jianning Jiang
EVOLUTIONARY PATTERNS OF HEPATITIS B VIRUS QUASISPECIES UNDER LAMIVUDINE TREATMENT AND ITS IMPACT ON RELAPSE
PP - 1669
Derya Seyman
WHAT IS THE ROLE OF ALANINE AMINOTRANSFERASE LEVEL AND LIVER BIOPSY FOR ANTIVIRAL THERAPY DECISION IN HBEAG
NEGATIVE CHRONIC HEPATITIS B WITH HBV DNA LEVEL BETWEEN 104 AND 105COPIES/ML?
PP - 1670
Yusuf Kayar
PP - 1671
Hussien Elsiesy
LIVER TRANSPLANTATION FOR PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS TYPE 3 (PFIC-3) PRESENTING IN THE 5TH
DECADE OF LIFE
PP - 1672
Fatma Ebru Akın
ENTECAVIR AND TENOFOVIR TREATMENT IN CIRRHOSIS DUE TO HEPATITIS B
PP - 1676
Seok Hyun Kim
PP - 1679
Gule Aydin
PP - 1682
Nesrin Turker
PP - 1688
Kyoung Min Sohn
PP - 1696
Tao Shen
PP - 1700
Sung Won Park
PP - 1702
Jianning Jiang
EFFECT OF ANTIVIRAL MONOTHERAPY ON RENAL FUNCTIONS IN CHRONIC HEPATITIS B PATIENTS
THE LONG-TERM OUTCOME OF CLEVUDINE THERAPY IN NAÏVE PATIENTS WITH CHRONIC HEPATITIS B
THE KNOWLEDGE OF HEALTHCARE WORKERS ABOUT THE PREVENTION OF MOTHER-TO-CHILD TRANSMISSION OF HEPATITIS B
VIRUS IN A SECOND STATE HOSPITAL, IN TURKEY.
COMPARISON OF THE EFFICACY OF TENOFOVIR AND ENTECAVIR FOR THE TREATMENT OF NUCLEOS(T)IDE-NAIVE CHRONIC
HEPATITIS B PATIENTS
ASSOCIATION BETWEEN NONALCOHOLIC FATTY LIVER DISEASE AND METABOLIC SYNDROME IN APPARENTLY HEALTHY KOREAN
ADULTS
SEQUENCE CHARACTERS OF HBV FROM CHINA AND ADJACENT COUNTRIES AND RELATIONSHIPS OF BCP/PREC MUTATION BETWEEN
CLINICAL STATUS
THE COMPARISON OF THERAPEUTIC RESPONSE BETWEEN ENTECAVIR AND TENOFOVIR IN THE TREATMENT-NAÏVE PATIENTS WITH
CHRONIC HEPATITIS B
EVOLUTIONARY PATTERNS OF HEPATOCYTE HEPATITIS B VIRUS CCCDNA BASAL CORE PROMOTER AND PRECORE QUASISPECIES AND
ITS IMPACT ON RELAPSE IN CHRONIC HEPATITIS B PATIENTS WITH LAMIVUDINE TREATMENT
PP - 1703
Soo Hyung Ryu
CAN EARLY VIRAL RESPONSE AT 1 MONTH PREDICT COMPLETE VIRAL RESPONSE AT 1 YEAR IN PATIENTS WITH CHRONIC HEPATITIS B
TREATED WITH TENOFORVIR DISPROXIL FUMARATE?
PP - 1705
Chhagan Bihari
QUANTITATIVE FIBROSIS ESTIMATION BY IMAGE ANALYSIS PREDICTS DEVELOPMENT OF DECOMPENSATION, AND COMPOSITE
EVENTS IN CHRONIC HEPATITIS B
PP - 1711
Jun Cheng
PP - 1713
Jianning Jiang
EVOLUTIONARY PATTERNS OF HEPATITIS B VIRUS QUASISPECIES UNDER LAMIVUDINE TREATMENT AND ITS IMPACT ON RELAPSE
PP - 1716
Chan Ran You
OBSTRUCTIVE SLEEP APNEA AS A RISK FACTOR OF NONALCOHOLIC FATTY LIVER DISEASE IN NON- OBESE PATIENTS
PP - 1717
Mehmet Celikbilek
EFFICACY AND SAFETY OF VILDAGLIPTIN FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS WITH NONALCOHOLIC FATTY LIVER
DISEASE
PP - 1719
Mehmet Celikbilek
ASSOCIATION OF CARDIOVASCULAR DISEASE RISK AND STEATOSIS SEVERITY IN NON-ALCOHOLIC FATTY LIVER DISEASE
PP - 1720
Chia-Yuan Liu
PP - 1721
Tao Shen
SEQUENCE CHARACTERS OF HBV FROM CHINA AND ADJACENT COUNTRIES AND RELATIONSHIPS OF BCP/PREC MUTATION WITH
CLINICAL STATUS
PP - 1726
Halil Genc
HIGH PLASMA LEVELS OF PENTRAXIN-3 IS ASSOCIATED WITH ENDOTHELIAL DYSFUNCTION IN NON-ALCOHOLIC FATTY LIVER DISEASE
PP - 1731
Ilyas Dokmetas
PP - 1737
Ching-Wei Chang
A CROSS-SECTIONAL STUDY ON INTRAHEPATIC CHOLESTASIS INDICATORS OF VIRAL HEPATITIS PATIENTS
THE EFFECT OF PROBIOTICS ON NONALCOHOLIC FATTY LIVER DISEASE AND METABOLIC DISORDER OF AGED OBESE MICE INDUCED
BY HIGH-FAT DIET
SERUM IP-10 LEVEL CORRALATES SIGNIFICANT FIBROSIS IN CHRONIC HEPATITIS B
NONALCOHOLIC STEATOHEPATITIS AND METABOLIC DISORDER OF DIFFERENT ORGANS IN YOUNG AND AGED DIET-INDUCED
OBESITY MODEL WITH C57BL/6 MICE
PP - 1740
Fatih Albayrak
RELATIONSHIP BETWEEN SERUM LEVELS OF ANGIOTENSIN-CONVERTING ENZYME, HISTOPATHOLOGIC ACTIVITY AND FIBROSIS IN
CHRONIC HEPATITIS B INFECTION
PP - 1741
Emin Altiparmak
LIVER BIOPSY RESULTS IN HBEAG NEGATIVE CHRONIC HBV PATIENTS WITH NORMAL ALT LEVELS AND HBV VIRAL LOAD BETWEEN
10.000 AND 100.000 COPY/ML
PP - 1750
Heidar Sharafi
COMPARISON OF SERUM HEPATITIS B VIRUS DNA AND HBSAG LEVELS BETWEEN HBEAG-NEGATIVE AND HBEAG-POSITIVE CHRONIC
HEPATITIS B PATIENTS
PP - 1753
Berivan Tunca
ACUTE HEPATIC FLAIR: CASE REPORT
PP - 1757
Ahmet Tarik Eminler
AST/ALT RATIO (AAR) IS NOT USEFUL TO PREDICT THE DEGREE OF FIBROSIS IN CHRONIC VIRAL HEPATITIS PATIENTS
PP - 1758
İsmail Hakkı Kalkan
PREDICTION OF SIGNIFICANT FIBROSIS AND NECROINFLAMMATION VIA NON-INVASIVE FIBROSIS MARKERS AMONG A SPECIFIC
PATIENT POPULATION WITH CHRONIC HEPATITIS B
PP - 1760
Cemal Bulut
PP - 1764
Husnu Pullukcu
PP - 1765
Eser Vardareli
VALUE OF CONTROLLED ATTENUATION PARAMETER (CAP) , LIVER ULTRASOUND AND METABOLIC PARAMETERS IN THE EVALUATION
OF STEATOSIS IN ASYMPTOMATIC ADULTS
PP - 1770
Gurkan Celebi
INSULIN RESISTANCE BUT NOT VISCERAL ADIPOSITY INDEX IS ASSOCIATED WITH LIVER FIBROSIS IN NONDIABETIC SUBJECTS WITH
NONALCOHOLIC FATTY LIVER DISEASE
PP - 1772
Laura Moreno-Luna
PP - 1773
Deniz Ozkaya
EVALUATION OF THE EFFECT OF TELBIVUDINE THERAPY ON RENAL FUNCTIONS IN PATIENT WITH CHRONIC HEPATITIS B
LIVER BIOPSY IN HEPATITIS CASES: BLINDED OR ULTRASONOGRAPHY GUIDED?
PREVALENCE OF LIVER FIBROSIS IN OBESE PATIENTS UNDERGOING BARIATRIC SURGERY COMPARING TRANSITIONAL ELASTOGRAPHY
VS BIOPSY
AUDIO AND VISUAL COMPLICATIONS AND MANAGEMENT OF THOSE IN CHRONIC HCV PATIENTS USED TELAPRAVIR + PEGYLATED
INTERFERON-ALPHA + RIBAVIRIN
PP - 1774
Halil Genc
TUMOR NECROSIS FACTOR LIKE WEAK INDUCER OF APOPTOSIS (TWEAK);
PP - 1776
Alper Gunduz
PP - 1779
Yuri Cho
EFFICACY OF ENTECAVIR-TENOFOVIR COMBINATION THERAPY FOR CHRONIC HEPATITIS B PATIENTS WITH MULTIDRUG-RESISTANT
STRAINS
PP - 1782
Jing You
EPIDEMIOLOGICAL CHARACTERISTICS AND CLINICAL FEATURES ON HIV CO-INFECTION WITH HBV AND/OR HCV
PP - 1784
Jing You
INCREASED SERUM LEVELS OF MIF, TGF-β, IL-17 AND IL-23 CORRELATE POSITIVELY WITH ACTIVE VIRAL REPLICATION AND
SEVERITY OF LIVER DISEASE IN CHRONIC HEPATITIS B
PP - 1789
Ayhan Balkan
THE EFFICACY OF LAMIVUDINE TREATMENT IN NAIVE CHRONIC HEPATITIS B PATIENTS
PP - 1790
Yanwei Zhong
THE RELATIONSHIP BETWEEN HEPATITIS B VIRUS PRE-S GENE MUTATION AND PROGRESSION OF LIVER DISEASE IN CHILDREN WITH
HEPATITIS B VIRUS INFECTION
PP - 1799
Wenting Li
PEG-INTERFERON A-2A UPREGULATES CD74 EXPRESSION IN PATIENTS WITH CHRONIC HEPATITIS B
PP - 1809
Kamil Özdil
THE EFFECTS OF TENOFOVIR AND ENTECAVIR THERAPY IN THE DEVELOPMENT OF OSTEOPOROSIS
PP - 1815
Lin Zhuang
SERUM MACROPHAGE MIGRATION INHIBITORY FACTOR, TRANSFORMING GROWTH FACTOR-β, INTERLEUKIN-17 AND
INTERLEUKIN-23 CONCENTRATIONS ARE ASSOCIATED WITH THE SEVERITY OF LIVER DISEASE IN PATIENTS WITH NONALCOHOLIC
FATTY LIVER DISEASE
PP - 1820
Sabiye Akbulut
PP - 1821
Jack Wallace
HIV/HBV COINFECTED PATIENT WITH HIGH HBV DNA LEVEL RESPONDING TO PEGYLATED INTERFERON TREATMENT : A CASE REPORT
HEART TRANSPLANTATION AND B HEPATITIS
VIRAL HEPATITIS CONTROL IN CHINA: A SYSTEMATIC IDENTIFICATION OF THE BARRIERS TO CLINICAL TREATMENT
PP - 1824
Kadri Atay
THE RESULTS OF 5 YEARS OF LAMIVUDINE THERAPY IN CHRONIC HEPATITIS B
PP - 1825
Huaie Liu
DECLINE OF HBVDNA LOAD CORRELATE WITH INCREASE OF TH17/TREG IMMUNITY IN CHRONIC HEPATITIS B PATIENTS DURING
LONG-TERM TREATMENT WITH COMBINING LAMIVUDINE AND ADEFOVIR DIPIVOXIL
PP - 1827
Yusuf Onlen
PP - 1830
Chao-Hung Hung
PP - 1833
Soon Woo Nam
PP - 1835
Mohammad Izazul Hoque
PP - 1839
Kyu Sik Jung
PP - 1846
Osman Cavit Ozdogan
PP - 1849
Ehab Abdelatty
PP - 1853
Muzzaffar Gill
OUTCOMES OF CHRONIC HEPATITIS B PATIENTS WHO DISCONTINUED NUCLEOS(T)IDE ANALOGUE THERAPY
PP - 1854
Muzzaffar Gill
OUT COMES OF THERAPEUTIC RESPONSE TO TENOFOVIR DIPIVOXIL FUMARATE (TDF) IN CHRONIC HEPATITIS B PREGNANT PATIENTS
PP - 1855
Muzzaffar Gill
ELEVATED SERUM LEVELS OF ALT ARE ASSOCIATED WITH METABOLIC SYNDROME INDEPENDENT OF FATTY LIVER DIAGNOSED BY
ULTRASOUND
A RARE SIDE EFFECT OF ENTECAVIR: HEPATOMEGALY AND STEATOSIS
LONG-TERM OUTCOMES OF HEPATITIS B VIRUS-RELATED CIRRHOSIS TREATED WITH NUCLEOS(T)IDE ANALOGUES
REACTIVATION OF HEPATITIS B VIRUS IN HBSAG-NEGATIVE PATIENTS WITH HEPATOCELLULAR CARCINOMA
OFF-THERAPY DURABILITY OF RESPONSE TO TELBIVUDINE THERAPY IN CHRONIC HEPATITIS B PATIENT IN BANGLADESH
CLINICAL OUTCOME AND PREDICTOR FOR RELAPSE AFTER CESSATION OF ORAL ANTIVIRAL TREATMENT IN CHRONIC HEPATITIS B
PATIENTS: PROSPECTIVE OBSERVATIONAL COHORT STUDY
PARTIAL VIROLOGIC RESPONSE DOES NOT TRANSLATE INTO SIMILAR OUTCOMES FOR LAMIVUDINE, ENTECAVIR AND TENOFOVIR IN
TREATMENT-NAIVE CHRONIC HEPATITIS B PATIENTS
OCCULT HEPATITIS B VIRUS INFECTION IN EGYPTIAN HEPATITIS C PATIENTS: PREVALENCE AND IMPACT ON HEPATOCELLULAR
CARCINOMA DEVELOPMENT
THE DISTRIBUTION AND DYNAMIC CHANGES OF SERUM 25(OH)D3 IN CHINESE CHRONIC HEPATITIS B PATIENTS WITH NUCLEOSIDE
ANALOGUE TREATMENT: RESULTS FROM A REAL-LIFE SETTING STUDY
PP - 1858
En-Qiang Chen
PP - 1863
Myeong Jun Song
PP - 1864
Muzzaffar Gill
LONG TERMS OUTCOMES OF ENTECAVIR AND TENOFOVIR COMBINATION THERAPY FOR CHRONIC HEPATITIS B IN PATIENTS WITH
PREVIOUS NUCLEOS(T)IDE TREATMENT FAILUR
PP - 1865
Muzzaffar Gill
LONG TERMS OUTCOMES TENOFOVIR DF (TDF) TREATMENT FOR CHRONIC HEPATITIS B PATIENTS
PP - 1869
D M Tan
PP - 1873
Hyoung Su Kim
PP - 1874
Hong Tang
THE PROFILE OF HEPATITIS B VIRUS GENOTYPIC RESISTANCE AND THE EFFICACY OF RESCUE THERAPY IN CLINICAL PRACTICE
PP - 1875
Hong Tang
FACTORS ASSOCIATED WITH MOTHER-TO-CHILD TRANSMISSION OF HEPATITIS B VIRUS DESPITE IMMUNOPROPHYLAXIS
PP - 1878
Jung Gil Park
ENTECAVIR PLUS ADEFOVIR OR ENTECAVIR PLUS TENOFOVIR FOR PATIENTS WITH CHRONIC HEPATITIS B RESISTANT TO
NEUCLEOT(S)IDE ANALOGUES.
PP - 1882
Longfeng Jiang
PP - 1883
Ping Shi
PP - 1886
Hitoshi Tajiri
SAFETY AND EFFICACY OF TENOFOVIR DISOPROXIL FUMARATE IN PATIENTS WITH CHRONIC HEPATITIS B RELATED DECOMPENSATED
CIRRHOSIS
THE IMPACTS OF BASELINE CLINICAL CHARACTERISTICS AND HEPATITIS B VIRUS MUTATIONS ON CURATIVE EFFECTS OF CHRONIC
HEPATITIS B TREATED WITH NOVAFERON
COMPARISON OF THE EFFICACY OF ENTECAVIR AND TENOFOVIR IN TREATMENT NAÏVE CHRONIC HEPATITIS B PATIENTS
THE VALUE OF FIHROTOUCH IN DIAGNOSIS OF HEPATIC FIBROSIS IN CHB PATIENTS AND INFLUENCING FACTORS
CLINICAL FEATURES OF CHRONIC HEPATITIS B PATIENTS AFTER STOPPING NUCLEOS(T)IDE ANALOGUES
EFFICACY OF COMBINATION THERAPY WITH NUCLEOTIDE ANALOGUES AND INTERFERON IN CHILDREN WITH GENOTYPE C HBV
CHRONIC HEPATITIS B
HEPATITIS-C AND B INFECTIONS AMONG HEALTH CARE WORKERS: A SERO EPIDEMIOLOGICAL STUDY AND “KNOWLEDGE
ATTITUDE AND PRACTICE” (KAP) SURVEY
PP - 1890
Harikumar Nair
PP - 1892
F. Haczeyni
PP - 1893
Hikmet Akkız
PP - 1896
Abu Saleh Md. Sadequl Islam
PP - 1897
Abu Saleh Md. Sadequl Islam CIRRHOSIS IS NOT MANDOTARY FOR THE DEVELOPMENT OF HEPATITIS B RELATED HEPATOCELLULAR CARCINOMA
FARNESOID X RECEPTOR ACTIVATION IMPROVES ADIPOSE/METABOLIC DYSFUNCTION AND LIVER HISTOLOGY IN MOUSE MODELS OF
NONALCOHOLIC FATTY LIVER DISEASE
ASSOCIATION BETWEEN CHRONIC HEPATITIS B VIRUS INFECTION AND HLA GENE RS3128917 AND RS9380343 POLYMORPHISMS
ASSOCIATION OF GENETIC VARIATION IN IL28B RS12979860 WITH THE DEVELOPMENT OF HEPATITIS B-RELATED HEPATOCELLULAR
CARCINOMA
PP - 1898
Zeynal Dogan
CAN MEAN PLATELET VOLUME PREDICT HBV DNA NEGATIVITY IN PATIENTS ON ANTIVIRAL TREATMENT FOR CHRONIC HEPATITIS B
PP - 1902
Madeeha Arshad
PP - 1903
Bora Jin
PP - 1905
Ying Li
PP - 1908
Tomoko Takano
PP - 1911
Konstantinos Mimidis
RENAL FUNCTION DURING 2 YEARS TREATMENT WITH TELBIVUDINE IN PATIENTS OVER 50 YEARS OLD – A
“FRESH” STUDY SUB-ANALYSIS (CLDT600AGR01)
PP - 1925
Tung-Hung Su
ACHIEVING ON-TREATMENT HBEAG LOSS SIGNIFICANTLY REDUCE CLINICAL RELAPSE AFTER ENTECAVIR THERAPY
TERATOGENESIS INDUCED BY IN UTERO EXPOSURE OF TRIMETHOPRIM SULFAMETHOXAZOLE IN MICE
ANALYZING THE MUTATION PATTERN OF MULTI-DRUG RESISTANT HEPATITIS B VIRUS DURING ENTECAVIR RESCUE THERAPY
CLINICAL SIGNIFICANCE OF SERUM FERRITIN IN PATIENTS WITH CHRONIC HEPATITIS B, HEPATITIS B VIRUS-RELATED CIRRHOSIS AND
HEPATOCELLULAR CARCINOMA
CLINICAL CHARACTERISTICS AND OUTCOME OF HEPATITIS B VIRUS-RELATED HEPATOCELLULAR CARCINOMA IN CHILDREN,
ADOLESCENTS, AND YOUNG ADULTS IN JAPAN
PP - 1936
Koichi Tsuneyama
DAILY MODERATE COFFEE INTAKE INHIBITS PANCREATIC BETA-CELL DAMAGE AND NONALCOHOLIC STEATOHEPATITIS WITHOUT
IMPROVING OBESITY IN A MOUSE MODEL OF SPONTANEOUS METABOLIC SYNDROME
PP - 1940
Sheng-Shun Yang
ASSOCIATION OF HEPATITIS B VIRUS INFECTION AND GLOMERULONEPHRITIS IN TAIWAN: A POPULATION-BASED CASE-CONTROLLED
STUDY
PP - 1942
Guangjun Song
PP - 1951
Sulabhsinh Solanki
PP - 1957
Ruifeng Yang
PERFORMANCE EVALUATION AND CLINICAL APPLICATION OF A NEWLY DEVELOPED ULTRA-SENSITIVE HEPATITIS B VIRUS SURFACE
ANTIGEN QUANTITATIVE ASSAY
PP - 1959
Chien-Hung Chen
COMBINATION OF AGE AND HEPATITIS B SURFACE ANTIGEN LEVELS IN PREDICTING HBV RELAPSE AFTER CESSATION OF ENTECAVIR
TREATMENT
PP - 1960
Ping Shi
PP - 1962
Mehmet İbis
PP - 1964
Mark Lester Sy
PP - 1966
Vedat Goral
PP - 1967
Md.Zia Hayder Bosunia
PP - 1972
Alpaslan Tanoglu
WITH A1574T MUTATION, HBV C TYPE CHRONIC HEPATITIS B PATIENTS HAVE THE TENDENCY OF SPONTANEOUS HBEAG
SEROCONVERSION
HYPERHOMOCYSTEINEMIA IN NON-CIRRHOTIC, INSULIN RESISTANT AND OBESE PATIENTS WITH NON-ALCOHOLIC FATTY LIVER
DISEASE
CLINICAL FEATURES OF CHRONIC HEPATITIS B PATIENTS AFTER STOPPING NUCLEOS(T)IDE ANALOGUES
PREDICTING FACTORS ABOUT LIVER HISTOLOGY IN INACTIVE CHRONIC HEPATITIS B PATIENTS
HEPATITIS B SURFACE ANTIGEN SERUM TITER: CORRELATION WITH HEPATITIS B VIRUS DNA AND ALANINE AMINOTRANSFERASE
LEVELS AMONG HEPATITIS B E ANTIGEN-NEGATIVE CHRONIC HEPATITIS B PATIENTS
NONALCOHOLIC STEATOHEPATITIS (NASH) IN 2 SIBLINGS
EVALUATION OF SERUM FERRITIN AS AN IMPORTANT PREDICTOR OF NON-ALCOHOLIC STEATOHEPATITIS
ASSOCIATION BETWEEN NEUTROPHIL TO LYMPHOCYTE RATIO, MEAN PLATELET VOLUME AND SEVERITY OF LIVER FIBROSIS IN
PATIENTS WITH CHRONIC HEPATITIS B
PEGYLATED INTERFERON ALFA-2A INDUCED CUTANEOUS LICHEN PLANUS AT THE ANTECUBITAL FOSSA AFTER VEIN PUNCTURE FOR
BLOOD SAMPLING
PP - 1976
Abdullah Emre Yıldırım
PP - 1983
Fatih Saygılı
PP - 1985
Kamuran Türker
PP - 1988
Alpay Arı
COMPARISION OF ONE YEAR THERAPEUTIC RESPONSE RATE OF FOUR ORAL ANTIVIRAL IN CHRONIC HEPATITIS B PATIENTS WITH
INITIAL LOW HBV DNA LEVEL
PP - 1989
Alpay Arı
EVALUATION OF CHRONIC HEPATITIS B PATIENTS’S CLINIC VARIABILITY ON FOLLOW UP
PP - 1990
Selma Tosun
DISTRIBUTION OF SUBJECTS WITH ACUTE VIRAL HEPATITIS IN ADULT AGE GROUP
PP - 1992
Selma Tosun
EVALUATION OF THE EFFECT OF UNIVERSAL HEPATITIS B VACCINATION AMONG CHILDREN ON THE PREVALANCE OF HEPATITIS B
VIRUS
PP - 1997
Selma Tosun
THE IMPORTANCE OF THE RESEARCHES ON HBSAG POSITIVITY IN PREGNANT WOMEN
PP - 1998
Selma Tosun
EVALUATION OF HEPATITIS B VIRUS INFECTION AMONG THE PARENTS OF THE INDIVIDUALS HAVING HBSAG POSITIVE
PP - 1999
Selma Tosun
THE RESULTS RELATED TO LONG TERM MONITORING OF THE BABIES OF HBSAG POSITIVE SUBJECTS DURING PREGNANCY
PP - 2000
Umaporn Limothai
PP - 2001
Selma Tosun
NONINVASIVE MARKERS FOR FIBROSIS IN CHRONIC HEPATITIS B: SUBSTITUTION FOR BIOPSY?
ALOPECIAE DUE TO ANTIVIRAL USAGE
IFNL3 (IL28B) AND IFNL4 POLYMORPHISMS ARE NOT ASSOCIATED WITH TREATMENT RESPONSE TO PEGYLATED INTERFERON IN THAI
PATIENTS WITH HBEAG-POSITIVE CHRONIC HEPATITIS B
MONITORING RESULTS OF 20 YEARS RELATED TO THE SUBJECTS HAVING HBSAG POSITIVE DURING PREGNANCY
PP - 2003
C. Wu
SERUM GAMMA-GLUTAMYLTRANSFERASE IS USEFUL FOR MONITORING NATURAL COURSE AND PREDICTING TREATMENT OUTCOME
OF CHRONIC HEPATITIS B VIRUS INFECTION
PP - 2011
C. Wu
INCREASE IN REGULATORY B CELLS AND INTERLEUKIN-10 IN IMMUNE REACTIVE PHASE OF CHRONIC HEPATITIS B VIRUS INFECTION
PP - 2012
Dipendra Raj Pandeya
PP - 2013
C. Wu
PP - 2017
Selma Tosun
PP - 2022
Yoon-Seok Chung
PP - 2026
R. Huang
PP - 2028
Manas Kumar Panigrahi
PP - 2029
T.T. Lao
RELATIONSHIP BETWEEN ALANINE TRANSAMINASE LEVEL AND HEPATITIS B VIRAL ACTIVITY IN MATERNAL CARRIERS OF HEPATITIS B
SURFACE ANTIGEN
PP - 2031
T.T. Lao
ALANINE TRANSAMINASE LEVEL INFLUENCES OBSTETRIC OUTCOME IN MATERNAL CARRIERS OF HEPATITIS B SURFACE ANTIGEN
PP - 2032
Mohammad Hosein Somi
PP - 2034
Sangheun Lee
EXPRESSION AND PURIFICATION OF ACTIVE RECOMBINANT REVERSE TRANSCRIPTASE DOMAIN OF HUMAN HEPATITIS B VIRUS
POLYMERASE
SERUM CYTOKINE/CHEMOKINE PROFILES DURING THE NATURAL COURSE OF CHRONIC HEPATITIS B
EVALUATION OF THE HEPATITIS B VIRUS EXPOSURE OF THE CHILDREN OF HBSAG POSITIVE MOTHERS
CHARACTERIZATION OF THE DYNAMICS OF HBV RESISTANCES AND GENETIC DIVERSITY FROM LONGITUDINALLY ANTIVIRAL THERAPY
TREATED PATIENTS WITH NEXT GENERATION SEQUENCING
ACCUMULATION OF PLATELETS IN THE LIVER MAY BE AN IMPORTANT CONTRIBUTORY FACTOR TO LIVER INJURY IN CHRONIC
HEPATITIS B VIRUS INFECTION
COMPARATIVE STUDY OF OLD VERSUS YOUNG NAFLD PATIENTS IN COASTAL EASTERN INDIA
DETERMINE EFFECT OF WEIGHT LOSS ON SERUM LEVEL OF INFLAMMATORY CYTOKINES IL-1, IL-6, CRP AND TNF-α IN OBESE
PATIENTS WITH FATTY LIVER DISEASE
THE PREDICTOR FOR VIROLOGIC RESPONSE IN MULTI-DRUG RESISTANT CHRONIC HEPATITIS B TREATED BY TENOFOVIR MONORESCUE THERAPY
COMPARING EFFICACY OF TENOFOVIR MONOTHERAPY AND TENOFOVIR BASED COMBINATION THERAPY IN ANTIVIRAL DRUG
RESISTANCE CHRONIC HEPATITIS B PATIENTS.
PP - 2035
Kyu Sik Jung
PP - 2037
Sheikh Mohammad Noor-E
Alam
PP - 2042
Ayyildiz T.
PP - 2045
Yang Liu
PP - 2049
Rahmet Guner
PP - 2053
Zeliha Kocak Tufan
PP - 2060
Haiyan Song
PP - 2062
Mehmet Demir
LONG-TERM RISK FACTORS OF MORTALITY IN HEPATITIS B VIRUS RELATED DECOMPENSATED CIRRHOSIS ON LAMIVUDINE,
ENTECAVIR AND TENOFOVIR THERAPY IN REAL-LIFE CLINICAL PRACTICE: A MULTICENTRE RETROSPECTIVE STUDY
PP - 2063
Ahmet Yozgat
CHANGINGS IN NASH PREDICTING NON-INVASIVE TESTS AFTER BARIATRIC SURGERY
PP - 2064
Pisit Tangkijvanich
PP - 2071
Ahmed Lutful Moben
PP - 2073
Hakan Cam
BIOCHEMICAL SCORING SYSTEM FOR DIAGNOSING NON-ALCOHOLIC STEATOHEPATITIS
INVESTIGATION OF GENOMIC INSTABILITY IN PERIPHERAL BLOOD LYMPHOCYTES OF PATIENTS WITH NONALCOHOLIC
STEATOHEPATITIS USING CHROMOSOME BREAKAGE AND MICRONUCLEUS ASSAYS
ALLEVIATION OF EARLY LIVER FIBROSIS IN MCD DIET-INDUCED NON-ALCOHOLIC STEATOHEPATITIS BY JIANG ZHI GRANULE
ANXIETY AND DEPRESSION IN CHRONIC HEPATITIS PATIENTS, A MULTI-CENTER STUDY
HEPATITIS PATHWAY FROM THE PATIENTS’ PERSPECTIVE
DIFFERENT EFFECT OF BERBERINE ON TWO MICE MODELS OF NONALCOHOLIC FATTY LIVER DISEASE
A RANDOMIZED STUDY COMPARING EFFICACY OF PEGINTERFERON-ALPHA-2B MONOTHERAPY VERSUS COMBINATION WITH
ENTECAVIR IN HBEAG-NEGATIVE CHRONIC HEPATITIS B
HEPATITIS B E ANTIGEN NEGATIVE CHRONIC HEPATITIS IN BANGLADESHI PATIENTS
THE ASSOCIATION BETWEEN SERUM HEPCIDIN AND HEPATIC FIBROSIS LEVELS IN PATIENTS WITH CHRONIC HEPATITIS B
PP - 2080
Aylin Calica Utku
52-WEEK EFFICACY OF TELBIVUDINE IN CHRONIC HEPATITIS B
PP - 2082
Oguzhan Ozturk
INCREASED SERUM SOLUBLE LECTIN-LIKE OXIDIZED LOW-DENSITY LIPOPROTEIN RECEPTOR-1 LEVELS IN PATIENTS WITH BIOPSYPROVEN NONALCOHOLIC FATTY LIVER DISEASE
PP - 2083
Gule Aydin
PP - 2085
Kamuran Türker
PP - 2087
Ibrahim Halil Bahcecioglu
PP - 2099
Vibhakorn Permpoon
PP - 2109
Hongliang He
THE SAFETY AND THERAPEUTIC EFFICACY EVALUATION FOR HUMAN UMBILICAL CORD MESENCHYMAL STEM CELLS
TRANSPLANTATION COMBINED WITH PLASMA EXCHANGE IN PATIENTS WITH LIVER FAILURE CAUSED BY HEPATITIS B VIRUS
PP - 2112
Müge Özgüler
RESEARCH OF EFFECTIVENES OF TENOFOVIR USED IN TREATMENT OF CHRONIC HEPATITIS B INFECTION ON BONE MINERALIZATION
PP - 2113
Bang-Fu Wu
A CLINICAL STUDY ON ANTI-HBV-DC INDUCING THERAPY IN THE NONACTIVE HBSAG CARRIERS
PP - 2114
Bang-Fu Wu
A CLINICAL STUDY ON ANTI-HBV-DC INDUCING THERAPY IN THE HBEAG POSITIVE CHRONIC HEPATITIS B VIRUS CARRIERS
PP - 2115
Bang-Fu Wu
A CLINICAL STUDY ON ANTI-HBV-DC INDUCING THERAPY IN THE HBEAG NEGATIVE CHRONIC HEPATITIS B VIRUS CARRIERS
PP - 2122
F. Fusun Bolukbas
THE INVESTIGATION AND FOLLOW-UP OF HBSAG POSITIVE PREGNANT WOMEN AND THEIR BABIES
TWO CASES OF TELBIVUDINE-INDUCED PERIPHERAL NEUROPATHY
HISTOPATHOLOGICAL, METABOLIC FEATURES AND ACE GENE POLYMORPHISM COMPARISON OF NON ALCOHOLIC FATTY LIVER
DISEASE
POTENTIAL RENAL PROTECTIVE EFFECT OF TELBIVUDINE IN PATIENTS WITH CHRONIC HEPATITIS B INFECTION COMPARED TO OTHER
ANTIVIRALS
IS THERE A RELATIONSHIP BETWEEN SEVERITIES OF FATTY INFILTRATIONS OF THE LIVER, WITH SILENT MYOCARDIAL ISCHEMIA, IN
OBESE PATIENTS?
PP - 2123
Müge Ozguler
EVALUATION OF IL-10 LEVELS IN PATIENTS DIAGNOSED WITH CHRONIC HEPATITIS
PP - 2129
Elif Sargın Altunok
PP - 2139
Noha Khalil
PP - 2143
Li Wang
PP - 2145
Cumhur Artuk
PP - 2147
Shilei Xu
PP - 2152
Hasan Karsen
DEEP BRADYCARDIA AND ACUTE HEPATITIS CAUSED BY ACUTE REACTIVATION OF CHRONIC HEPATITIS B: THREE CASE REPORT
PP - 2154
Selma Tosun
THE EFFICACY OF BOOSTER VACCINATION IN UNIVERSALLY HBV-VACCINATED CHILDREN CHILDREN
PP - 2155
Selma Tosun
THE EVALUATION OF HBV PREVALENCE IN CHILDREN
PP - 2156
Angela Peltec
NONALCOHOLIC FATTY LIVER DISEASE WITH AND WITHOUT METABOLIC SYNDROME – TWO DIFFERENT DISORDERS: YES OR NO?
PP - 2157
Şükran Köse
EFFICACY OF TENOFOVIR IN HEPATITIS B PATIENTS WHO NON-RESPONSE TO PEGYLATED INTERFERON TREATMENT
PP - 2158
Ugur Korkmaz
THE EXAMINATION OF MUTATIONS CREATED BY PEGYLATED INTERFERON ALPHA AND ORAL ANTIVIRALS USED IN THE TREATMENT
OF CHRONIC HEPATITIS B ON HBSAG GENE AND POLYMERASE GENE
EVALUATION OF SERUM FERRITIN IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
IMPACT OF ADHERENCE TO ANTIVIRAL THERAPY AND OUTCOMES IN PATIENTS WITH CHRONIC HEPATITIS B INFECTION
EFFECT OF HBEAG SEROCONVERSION OVER THE LIVER HISTOLOGY
EFFECT OF HEPATIC B VIRUS INFECTION ON LIVER METASTASES IN COLORECTAL CANCER
HISTOPATHOLOGICAL EVALUATION IN INACTIVE HEPATITIS B CARRIERS
PP - 2159
Angela Peltec
IS HEMOGLOBIN LEVEL PREDICTED THE STAGE OF NONALCOHOLIC FATTY LIVER DISEASE UNRELATED WITH THE METABOLIC
SYNDROMES?
PP - 2160
Ugur Korkmaz
RELATIONSHIP BETWEEN HISTOPATHOLOGIC FEATURES AND SERUM COMPLEMENT LEVEL FOR INATIVE HEPATITIS B CARRIERS
PP - 2161
Ugur Korkmaz
SPONTANEOUS VACCINE ESCAPE MUTATION IN INACTIVE HEPATITIS B CARRIERS AND ITS IMPORTANT
PP - 2162
Fusun F. Bolukbas
PP - 2168
Ali Demır
USE OF NON-INVASIVE TESTS TO PREDICT LIVER FIBROSIS IN CHRONIC HEPATITIS B
PP - 2174
Güray Can
ALOPECIA AREATA; A RARE COMPLICATION OF TENOFOVIR DISOPROXIL FUMARATE IN CHRONIC HAPATITIS B
PP - 2177
Iulianna Lupasco
PP - 2179
Ozlem Altuntas Aydin
PP - 2180
Bulent Yilmaz
THE RELATIONSHIP BETWEEN FIBROSIS LEVEL AND BLOOD NEUTROPHIL TO LYMPHOCYTE RATIO IN INACTIVE HEPATITIS B CARRIERS
PP - 2184
Ayse Batirel
SEVERE HEPATIC FLARE AND HBEAG-SEROREVERSION IN TWO PATIENTS WITH HBEAG-POSITIVE CHRONIC HEPATITIS B DEVELOPING
AFTER DISCONTINUATION OF ORAL ANTIVIRAL THERAPY ONE YEAR AFTER HBEAG-SEROCONVERSION
PP - 2187
Rıdvan Kara Ali
THE EVALUATION OF SOME HEMATOLOGICAL PARAMETERS AT PATIENTS WITH CHRONIC INACTIVE HEPATITIS B VIRUS INFECTION
PP - 2191
Ugur Korkmaz
NATURALLY DEVELOPING HBV POLIMERASE AND SUPERFICIAL GENE VARIANTS IN INACTIVE HEPATITIS B CARRIERS
INTRAHEPATIC CHOLESTASIS OF PREGNANCY IN SPONTANEOUS AND IN VITRO FERTILIZATION
PROLACTIN KINETICS IN PATIENTS WITH CHRONIC HEPATITIS B
TRANSMISSION ROUTES OF HEPATITIS B VIRUS IN ISTANBUL, TURKEY
PP - 2192
Mustafa Altindis
HBSAG, ANTI-HCV, ANTI-HIV 1/2 AND SYPHILIS SEROPREVALENCE IN HEALTHY VOLUNTEER BLOOD DONORS IN EASTERN MARMARA
REGION, TURKEY
PP - 2193
Ugur Korkmaz
THE RELATIONSHIP BETWEEN FIBROSIS LEVEL AND BLOOD NEUTROPHIL TO LYMPHOCYTE RATIO IN INACTIVE HEPATITIS B CARRIERS
PP - 2194
Beytullah Yıldırım
PP - 2196
N. Ormeci
DOES TENOFOVIR TREATMENT IN CHRONIC HBV INFECTION INHIBIT OCCURRENCE OF LIVER CIRRHOSIS AND HEPATOCELLULAR
CARCINOMA?
PP - 2198
N. Ormeci
NATURAL COURSE OF PATIENTS WITH CARRIER OF HEPATITIS B VIRUS INFECTION. LONG TERM OUTCOME
PP - 2199
Philippa Easterbrook
NEW WHO GUIDELINES FOR CARE AND TREATMENT OF PERSONS WITH CHRONIC HEPATITIS B (CHB) INFECTION IN RESOURCE
LIMITED SETTINGS (RLS)
PP - 2200
Philippa Easterbrook
REGIONAL SEROPREVALENCE AND BURDEN OF HIV-HBV COINFECTION: A GLOBAL SYSTEMATIC REVIEW
PP - 2201
Mustafa Cengiz
PP - 2206
Hasan Ozkan
PP - 2209
Ibrahim Halil Bahcecioglu
PP - 2210
Hong Tang
THE SERUM ANTI-HBS LEVELS AMONG CHILDREN AGED 15 AND YOUNGER WHO RECEIVED ROUTINE HEPATITIS B VACCINATION
DURING INFANCY IN MIANYANG CITY, A TYPICAL CITY OF SOUTHWEST CHINA: A CROSS-SECTIONAL STUDY
PP - 2211
Hong Tang
PREVALENCE OF HEPATITIS B VIRUS INFECTION IN WESTERN CHINA: EPIDEMIOLOGICAL SURVEY RESULTS OF GENERAL ADULT
POPULATION IN MIANYANG
EFFECT OF NUCLEOS(T)IDE ANALOGUES ON RENAL FUNCTION IN PATIENTS WITH CHRONIC HEPATITIS B
THE ROLES OF INTERLEUKIN-6 AND INTERLEUKIN-8 GENE POLYMORPHISMS IN THE NON-ALCOHOLIC STEATOHEPATITIS
SUSTAINED VIROLOGICAL RESPONSE IN DUAL INFECTION OF CHRONIC HEPATITIS B AND C VIRUS
RIFAXIMIN PROTECTS AGAINST THE DEVELOPMENT OF FRUCTOSE-INDUCED STEATOHEPATITIS IN RATS
PP - 2213
Alpaslan Tanoglu
HEPATIC STEATOSIS: A NOVEL CORONARY RISK FACTOR FOR AVIATORS?
PP - 2223
Mehmet Celikbilek
URIC ACID LEVEL AND ERECTILE DYSFUNCTION IN PATIENTS WITH NAFLD
PP - 2224
Jong Won Kim
CHRONIC ADMINISTRATION OF NICOTINE EXACERBATES NONALCOHOLIC STEATOHEPATITIS VIA INCREASED HEPATIC FAT LOSS AND
FIBROSIS
PP - 2226
Bumseok Kim
TOLL-LIKE RECEPTOR 7 PROMOTES NON-ALCOHOLIC STEATOHEPATITIS BY INDUCTION OF TUMOR NECROSIS FACTOR- α IN
MICE
PP - 2227
Arif Mansur Cosar
PP - 2230
Ercan Bicakci
PP - 2235
Ramin Farajpour
A CASE OF ACUTE FATTY LIVER OF PREGNANCY,SECOND TRIMESTER OF PREGNANCY
PP - 2239
Omer Ozturk
PERCEIVED SOCIAL SUPPORT AND QUALITY OF LIFE IN PATIENTS WITH HEPATITIS B
IS SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR NEW NON-INVASIVE MARKER IN PATIENTS WITH CHRONIC HEPATITIS
B INFECTION?
SERUM LEVELS AND LIVER DISTRIBUTION OF MYELOPEROXIDASE AND CALPROTECTIN IN NASH PATIENTS